NASDAQ:PHAS - PhaseBio Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$6.75 +0.51 (+8.17 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$6.75
Today's Range$6.1160 - $6.80
52-Week Range$2.55 - $8.88
Volume186,460 shs
Average Volume447,798 shs
Market Capitalization$165.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

PhaseBio Pharmaceuticals (NASDAQ PHAS) News Headlines

Source:
DateHeadline
PhaseBio Pharmaceuticals (PHAS) Scheduled to Post Earnings on TuesdayPhaseBio Pharmaceuticals (PHAS) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - March 20 at 8:34 AM
PhaseBio Pharmaceuticals, Inc. (PHAS) Pre-Market TradingPhaseBio Pharmaceuticals, Inc. (PHAS) Pre-Market Trading
www.nasdaq.com - March 19 at 3:43 PM
PhaseBio To Report Fourth Quarter and Full-Year 2018 Financial and Business Results on March 26, 2019PhaseBio To Report Fourth Quarter and Full-Year 2018 Financial and Business Results on March 26, 2019
finance.yahoo.com - March 19 at 3:43 PM
PhaseBio Stock Up on Positive Data From PB2452 Phase I StudyPhaseBio Stock Up on Positive Data From PB2452 Phase I Study
finance.yahoo.com - March 19 at 3:43 PM
Brokerages Anticipate PhaseBio Pharmaceuticals Inc (PHAS) to Post ($0.29) Earnings Per ShareBrokerages Anticipate PhaseBio Pharmaceuticals Inc (PHAS) to Post ($0.29) Earnings Per Share
www.americanbankingnews.com - March 18 at 8:17 PM
Full Results from PhaseBio Phase 1 Clinical Trial...Full Results from PhaseBio Phase 1 Clinical Trial...
www.benzinga.com - March 18 at 10:18 AM
PhaseBios stock more than doubles after positive phase 1 trial results of ticagrelor reversal agentPhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent
www.marketwatch.com - March 18 at 10:18 AM
What Its Antiplatelet Reversal Agent Means for PhaseBio Going ForwardWhat Its Antiplatelet Reversal Agent Means for PhaseBio Going Forward
247wallst.com - March 18 at 10:18 AM
PhaseBio up 102% premarket on positive PB2452 dataPhaseBio up 102% premarket on positive PB2452 data
seekingalpha.com - March 18 at 10:18 AM
Full Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal ofFull Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal of
www.nasdaq.com - March 17 at 3:33 PM
Full Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal of Medicine and Presented at the American College of Cardiology’s 68th Annual Scientific SessionFull Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal of Medicine and Presented at the American College of Cardiology’s 68th Annual Scientific Session
finance.yahoo.com - March 17 at 3:33 PM
PhaseBio Pharmaceuticals Inc (PHAS) Expected to Post Earnings of -$0.29 Per SharePhaseBio Pharmaceuticals Inc (PHAS) Expected to Post Earnings of -$0.29 Per Share
www.americanbankingnews.com - March 15 at 8:22 PM
PhaseBio Pharmaceuticals Inc.PhaseBio Pharmaceuticals Inc.
www.barrons.com - March 13 at 10:29 AM
PhaseBio to Present at Cowen and Company 39th Annual Health Care ConferencePhaseBio to Present at Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 6 at 9:29 AM
PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Presentation at the American College of Cardiology’s 68th Annual Scientific SessionPhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Presentation at the American College of Cardiology’s 68th Annual Scientific Session
finance.yahoo.com - March 4 at 8:32 AM
PhaseBio Appoints Richard A. van den Broek to Board of DirectorsPhaseBio Appoints Richard A. van den Broek to Board of Directors
finance.yahoo.com - March 4 at 8:32 AM
A few minutes with... PhaseBio CEO Jonathan MowA few minutes with... PhaseBio CEO Jonathan Mow
finance.yahoo.com - January 10 at 3:22 PM
PhaseBio Appoints Edmund P. Harrigan to Board of DirectorsPhaseBio Appoints Edmund P. Harrigan to Board of Directors
finance.yahoo.com - December 18 at 6:52 AM
The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBios First EarningsThe Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings
finance.yahoo.com - November 30 at 3:17 PM
PhaseBio Pharmaceuticals EPS of -$10.45PhaseBio Pharmaceuticals EPS of -$10.45
seekingalpha.com - November 30 at 5:55 AM
PhaseBio ends Q3 with $24.3M in cash and equivalentsPhaseBio ends Q3 with $24.3M in cash and equivalents
seekingalpha.com - November 30 at 5:55 AM
PhaseBio Reports Third Quarter 2018 Financial and Business ResultsPhaseBio Reports Third Quarter 2018 Financial and Business Results
finance.yahoo.com - November 30 at 5:55 AM
Dosing underway in Phasebios mid-stage study of PB1046 in PAH; shares up 3%Dosing underway in Phasebio's mid-stage study of PB1046 in PAH; shares up 3%
seekingalpha.com - November 27 at 3:16 PM
PhaseBio Announces Dosing of First Patient in Phase 2b Clinical Trial of PB1046 in Pulmonary Arterial HypertensionPhaseBio Announces Dosing of First Patient in Phase 2b Clinical Trial of PB1046 in Pulmonary Arterial Hypertension
finance.yahoo.com - November 27 at 3:16 PM
The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEOThe Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO
www.msn.com - November 21 at 3:15 PM
PhaseBio To Report Third Quarter 2018 Financial and Business Results on November 29, 2018PhaseBio To Report Third Quarter 2018 Financial and Business Results on November 29, 2018
finance.yahoo.com - November 21 at 3:15 PM
PhaseBios IPO: What You Need To KnowPhaseBio's IPO: What You Need To Know
finance.yahoo.com - November 12 at 1:54 PM
PhaseBio Announces Pricing of Initial Public OfferingPhaseBio Announces Pricing of Initial Public Offering
finance.yahoo.com - November 12 at 1:54 PM
PhaseBio to Present at Stifel 2018 Healthcare ConferencePhaseBio to Present at Stifel 2018 Healthcare Conference
finance.yahoo.com - November 12 at 1:54 PM
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: What is Call Option Volume?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel